OptiBiotix Health Plc (LON:OPTI – Get Free Report) insider Stephen O’Hara purchased 95,238 shares of the stock in a transaction on Tuesday, September 23rd. The stock was acquired at an average cost of GBX 11 per share, for a total transaction of £10,476.18.
Stephen O’Hara also recently made the following trade(s):
Get OptiBiotix Health alerts:
On Monday, September 22nd, Stephen O’Hara purchased 50,000 shares of OptiBiotix Health stock. The stock was acquired at an average cost of GBX 10 per share, for a total transaction of £5,000.
OptiBiotix Health Stock Performance
LON:OPTI opened at GBX 10.22 on Thursday. OptiBiotix Health Plc has a one year low of GBX 9 and a one year high of GBX 23.50. The firm has a market cap of £10.56 million, a price-to-earnings ratio of -555.43 and a beta of 1.71. The firm’s fifty day moving average is GBX 11 and its two-hundred day moving average is GBX 13.90.
OptiBiotix Health (LON:OPTI – Get Free Report) last posted its quarterly earnings results on Tuesday, September 16th. The company reported GBX (1.15) EPS for the quarter. OptiBiotix Health had a negative net margin of 524.43% and a negative return on equity of 36.76%.
OptiBiotix Health Company Profile
(Get Free Report)
OptiBiotix Health plc (AIM: OPTI), which was formed in March 2012, brings science to the development of compounds which modify the human microbiome – the collective genome of the microbes in the body – in order to prevent and manage human disease and promote wellness.
OptiBiotix has an extensive R&D programme working with leading academics in the development of microbial strains, compounds, and formulations which are used as active ingredients and supplements.
Featured Stories
Five stocks we like better than OptiBiotix Health
How to Evaluate a Stock Before Buying
Cybersecurity Market Set to Double: This ETF Offers Exposure
3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
Downgraded But Not Done: 3 Stocks Ready for a Market Comeback
Stock Sentiment Analysis: How it Works
Solana Beat BTC and ETH in Q3: These 3 Stocks Saw It Coming
